Institutional Shareholder Services has recommended Pfizer investors reject a proposal on executive compensation at its ...

Just hours after thousands of U.S. Food and Drug Administration employees were shown the door, Barclay Butler, the agency’s ...

Donald Trump takes biopharma on a tariff-themed rollercoaster ride; J&J kicks off the Q1 earnings season; experts express concern about the FDA’s future; Pfizer’s obesity setback could be Viking’s ...

Albert Bourla, head of Pfizer ... around executive pay, saying that Britain needed to attract top talent and discourage firms from decamping overseas. Soriot's pay has stirred controversy with ...

(Reuters) -Institutional Shareholder Services has recommended Pfizer investors ... and undermine a "pay-for-performance philosophy", ISS said. Annual incentives for executives are tied to ...